UNICREDIT BANK/CALL/ELI LILLY & CO/1280/0.1/17.12.25 | Market Closed - Bid/Ask 15:41:37 2024-06-04 EDT | After market 15:59:35 | |||
| 3.71 EUR | 0.00% |
|
3.825 | +3.10% |
| Current month | +6.00% | ||
| 1 month | +55.88% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 3.71 | 0.00% |
| 24-06-03 | 3.71 | +6.00% |
| 24-05-31 | 3.5 | 0.00% |
| 24-05-30 | 3.5 | +2.34% |
| 24-05-29 | 3.42 | 0.00% |
Real-time BOERSE MUENCHEN
Last update June 04, 2024 at 03:41 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HD4XL6 |
| ISIN | DE000HD4XL65 |
| Date issued | 2024-04-23 |
| Strike | 1,280 $ |
| Maturity | 2025-12-17 (561 Days) |
| Parity | 10 : 1 |
| Emission price | 2.78 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.71 € |
|---|---|
| Lowest since issue | 2.17 € |
| Delta | 0.25x |
| Omega | 4.952 |
| Premium | 58.62x |
| Gearing | 19.97x |
| Moneyness | 0.6510 |
| Difference Strike | 447.4 $ |
| Difference Strike % | +34.95% |
| Spread | 0.21 € |
| Spread % | 5.33% |
| Theoretical value | 3.760 |
| Implied Volatility | 33.64 % |
| Total Loss Probability | 86.57 % |
| Intrinsic value | 0.000000 |
| Present value | 3.760 |
| Break even | 1,320.75 € |
| Theta | -0.07x |
| Vega | 0.29x |
| Rho | 0.23x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
831.3
USD
Average target price
852.5
USD
Spread / Average Target
+2.56%
- Stock Market
- Warrants
- Warrant
